Increased visceral adipocyte lipolysis - A pathogenic role in nonalcoholic fatty liver disease?

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 10, 2010, Pages

  Thörne, Anders ^a,b   Löfgren, Patrik ^a,c   Hoffstedt, Johan ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Södertälje Hospital   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUCLADESINE; FATTY ACID; GLYCEROL; ISOPRENALINE; NORADRENALIN; TRIACYLGLYCEROL;

ABDOMINAL FAT ASPIRATION BIOPSY; ADIPOCYTE; ADULT; ARTICLE; BODY FAT; BODY FAT DISTRIBUTION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INTRAABDOMINAL FAT; LIPID LIVER LEVEL; LIPID STORAGE; LIPOLYSIS; MORBID OBESITY; NONALCOHOLIC FATTY LIVER; PATHOGENESIS; PRIORITY JOURNAL; SUBCUTANEOUS FAT;

EID: 77957812160     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0520     Document Type: Article

References (20)

1. Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH 2009 Metabolic disturbances in non-alcoholic fatty liver disease. Clin Sci (Lond) 116:539-564
2. Fan JG, Farrell GC 2008 VAT fat is bad for the liver, SAT fat is not! J Gastroenterol Hepatol 23:829-832
3. Verna EC, Berk PD 2008 Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. Semin Liver Dis 28:407-426
4. Fabbrini E, Mohammed BS, Magkos F, Korenblat KM, Patterson BW, Klein S 2008 Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 134:424-431 (Pubitemid 351173050)
5. Fabbrini E, deHaseth D, Deivanayagam S, Mohammed BS, Vitola BE, Klein S 2009 Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content. Obesity 17: 25-29
6. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ 2005 Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115:1343-1351 (Pubitemid 40629054)
7. Hodson L, Bickerton AS, McQuaid SE, Roberts R, Karpe F, Frayn KN, Fielding BA 2007 The contribution of splanchnic fat to VLDL triglyceride is greater in insulin-resistant than insulin-sensitive men and women: studies in the postprandial state. Diabetes 56:2433-2441 (Pubitemid 47523250)
8. Park BJ, Kim YJ, Kim DH, Kim W, Jung YJ, Yoon JH, Kim CY, Cho YM, Kim SH, Lee KB, Jang JJ, Lee HS 2008 Visceral adipose tissue area is an independent risk factor for hepatic steatosis. J Gastroenterol Hepatol 23:900-907
9. van der Poorten D, Milner KL, Hui J, Hodge A, Trenell MI, Kench JG, London R, Peduto T, Chisholm DJ, George J 2008 Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 48:449-457
10. Vega GL, Chandalia M, Szczepaniak LS, Grundy SM 2007 Metabolic correlates of nonalcoholic fatty liver inwomenand men. Hepatology 46:716-722 (Pubitemid 47436117)
11. Gallagher D, Visser M, Sepúlveda D, Pierson RN, Harris T, Heymsfield SB 1996 How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol 143: 228-239
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 (Pubitemid 15018832)
13. Kolaczynski JW, Morales LM, Moore Jr JH, Considine RV, Pietrzkowski Z, Noto PF, Colberg J, Caro JF 1994 A new technique for biopsy of human abdominal fat under local anaesthesia with lidocaine. Int J Obes Relat Metab Disord 18:161-166 (Pubitemid 24087130)
14. Reynisdottir S, Wahrenberg H, Carlström K, Rössner S, Arner P 1994 Catecholamine resistance in fat cells of women with upperbody obesity due to decreased expression of β2-adrenoceptors. Diabetologia 37:428-435 (Pubitemid 24113577)
15. Lönnqvist F, Thöme A, Nilsell K, Hoffstedt J, Arner P 1995 A pathogenic role of visceral fat β3-adrenoceptors in obesity. J Clin Invest 95:1109-1116
16. Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F 2009 Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 51:433-445
17. Kotronen A, Peltonen M, Hakkarainen A, Sevastianova K, Bergholm R, Johansson LM, Lundbom N, Rissanen A, Ridderstråle M, Groop L, Orho-Melander M, Yki-Järvinen H 2009 Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology 137:865-872
18. Arner P 2005 Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab 19:471-482 (Pubitemid 41819214)
19. Thörne A, Lönnqvist F, Apelman J, Hellers G, Arner P 2002 A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord 26:193-199 (Pubitemid 34151196)
20. Porter SA, Massaro JM, Hoffmann U, Vasan RS, O'Donnel CJ, Fox CS 2009 Abdominal subcutaneous adipose tissue: a protective fat depot? Diabetes Care 32:1068-1075